Rh Factor and Pregnancy: What Indian Women With Rh-Negative Blood Need to Know
A clear guide to Rh factor in pregnancy — what Rh-negative blood means, what Rh incompatibility is, and how anti-D injections protect future pregnancies.
At your first antenatal blood test, among the results that come back is your blood group — A, B, AB, or O — and your Rh factor: positive or negative. For the majority of women, the result is Rh-positive, and the Rh factor requires no further attention. For a smaller group — women who are Rh-negative — the result matters specifically in the context of pregnancy, and understanding what it means is important.
Rh factor is not a disease or a deficiency. It is simply a characteristic of blood — specifically, whether a protein called the Rh(D) antigen is present on the surface of red blood cells. If it is present, you are Rh-positive. If it is absent, you are Rh-negative.
In most of life, Rh factor is medically relevant only when it comes to blood transfusions. In pregnancy, it becomes relevant in a specific and important way: when an Rh-negative mother carries an Rh-positive baby, there is a risk of the mother’s immune system developing antibodies against the baby’s blood — a process called Rh sensitisation, which can have consequences for the current and future pregnancies.
The good news is that the prevention of Rh sensitisation is well understood, effective, and available. This is a manageable situation, not a dangerous one — provided it is identified and appropriately addressed.
How common is Rh-negative blood in India?
Rh-negative blood is less common in South Asian populations than in European ones. While approximately fifteen percent of people of European descent are Rh-negative, the proportion among South Asians is considerably lower — approximately five to eight percent. Among some groups in India, it is even rarer.
This means that Rh-negative blood in an Indian woman is genuinely uncommon, and it is one reason why the topic may not have been widely discussed in your community — most women simply have not needed to think about it.
If you are Rh-negative, your blood group result will show your ABO type followed by a negative sign — for example, O negative, A negative, B negative, or AB negative. This should be documented clearly in your antenatal records, and you should know your blood group.
What Rh incompatibility means — and how it develops
Rh incompatibility in pregnancy occurs when an Rh-negative mother carries an Rh-positive baby. The baby’s Rh factor is inherited — if the father is Rh-positive, the baby may be Rh-positive even if the mother is Rh-negative.
Under normal circumstances, the mother’s and baby’s blood do not mix significantly during pregnancy. However, small amounts of fetal blood can cross into the maternal circulation — particularly at delivery, but also at other points during pregnancy. If the baby’s Rh-positive red blood cells enter the mother’s Rh-negative blood, the mother’s immune system may recognise them as foreign and produce anti-D antibodies.
This process is called Rh sensitisation. Once sensitised, the mother’s immune system has the antibodies on file — and in any subsequent pregnancy with an Rh-positive baby, those antibodies can cross the placenta and attack the baby’s red blood cells. This causes haemolytic disease of the fetus and newborn (HDFN) — a condition that ranges from mild jaundice in the newborn to severe anaemia, organ damage, and, in untreated severe cases, death.
The critical point is that the first Rh-positive pregnancy typically does not cause significant problems, because sensitisation usually occurs at delivery — after the baby has already been born. It is the subsequent pregnancies that are at risk. This is why prevention of sensitisation in the first pregnancy — before any exposure has occurred — is so important.
When sensitisation can occur during a pregnancy
Sensitisation does not only happen at delivery. Fetal-maternal blood mixing can occur at other points, which is why anti-D prophylaxis is given after any of the following events in an Rh-negative woman:
- Delivery (vaginal or caesarean)
- Miscarriage (spontaneous or induced), at any gestation
- Ectopic pregnancy
- Chorionic villus sampling (CVS)
- Amniocentesis
- External cephalic version (manually turning a breech baby)
- Significant abdominal trauma during pregnancy
- Antepartum haemorrhage (bleeding during pregnancy)
- Intrauterine death
In each of these situations, there is potential for fetal blood to enter the maternal circulation, and anti-D immunoglobulin should be given promptly — usually within seventy-two hours of the sensitising event.
What anti-D immunoglobulin is and how it works
Anti-D immunoglobulin is an injection given to Rh-negative women to prevent sensitisation. It contains antibodies against Rh(D)-positive blood cells — administered before the mother’s immune system has had time to produce its own antibodies, it neutralises any Rh-positive fetal cells that have entered the maternal circulation, preventing sensitisation from occurring.
It is a preventive treatment — not a cure for existing sensitisation, and not a treatment for the current pregnancy if sensitisation has already occurred. It works by getting ahead of the immune response before it develops.
Routine antenatal prophylaxis: In many countries, anti-D is given routinely to all Rh-negative pregnant women at twenty-eight weeks of pregnancy (and sometimes again at thirty-four weeks), regardless of known sensitising events. This is because small amounts of fetal-maternal bleeding can occur without any identifiable trigger.
In India, practice varies: Routine prophylaxis at twenty-eight weeks is standard in many private hospitals and tertiary care centres but is not uniformly available or offered across all settings. In some facilities, anti-D is given only after identifiable sensitising events rather than routinely. If you are Rh-negative and approaching twenty-eight weeks, it is worth specifically asking your provider about their protocol.
After sensitising events: Anti-D is given within seventy-two hours of the event. The dose depends on the estimated volume of fetal blood that may have entered the maternal circulation — for most first-trimester events, a smaller dose is used; for delivery and later-pregnancy events, a larger dose.
If you are already sensitised
If anti-D antibodies are detected in your blood — meaning sensitisation has already occurred — anti-D immunoglobulin will not reverse this. The approach shifts from prevention to management:
- Indirect Coombs test (antibody titre) is monitored regularly to assess the level of anti-D antibodies in your blood
- Fetal Middle Cerebral Artery (MCA) Doppler — an ultrasound measurement of blood flow in the baby’s brain — is used to monitor for signs of fetal anaemia without invasive testing
- If significant fetal anaemia develops, intrauterine blood transfusion may be required
- Delivery timing and neonatal management are planned in advance
Management of sensitised Rh pregnancies is done in specialist centres with maternal-fetal medicine expertise. If you have been found to be sensitised, your care will be escalated to an appropriate facility.
What to do if your partner is also Rh-negative
If both you and the baby’s father are Rh-negative, the baby will also be Rh-negative, and there is no risk of Rh incompatibility. In this specific situation, anti-D prophylaxis is not required.
In practice, paternal Rh status is not always known, and some providers give anti-D to all Rh-negative women regardless — particularly after sensitising events — because the benefit when the father is Rh-positive far outweighs any cost when he is not.
Paternal Rh typing can be done through a simple blood test and, if he is confirmed Rh-negative, removes the need for anti-D in current and future pregnancies with the same partner.
Carrying information about your blood group
Because Rh-negative status matters whenever blood products or pregnancy events occur, it is worth knowing your blood group and having it documented in a form you carry with you. Your antenatal card or pregnancy notes should include this information. In an emergency — if you needed blood products or arrived at an unfamiliar hospital — this information is clinically important.
A note specific to the Indian context
Several aspects of Rh factor management in pregnancy are worth flagging specifically for India:
Availability of anti-D: Anti-D immunoglobulin is available in India but may not be consistently stocked at all facilities. In rural and smaller centres, availability may be limited. Women who are Rh-negative and who are being monitored in a facility where anti-D availability is uncertain should confirm with their provider that it will be on hand if needed — particularly for delivery.
Awareness: Because Rh-negative blood is less common in Indian populations, there may be less community awareness of what it means. Family members, mothers-in-law, and even some providers in settings with lower case volume may not be familiar with the details of Rh management. Understanding the issue yourself means you can advocate for appropriate care if needed.
Miscarriage management: Women who experience a miscarriage — which, statistically, affects a significant proportion of pregnancies — should ensure their Rh status is known and that anti-D is given if they are Rh-negative. This is sometimes missed in the management of early pregnancy loss.
The honest message
If you are Rh-negative, this is a characteristic of your blood that requires specific management in pregnancy — not a diagnosis, not something that went wrong, and not something that makes your pregnancy inherently high-risk. With appropriate anti-D prophylaxis at the right moments, Rh sensitisation is largely preventable.
Know your blood group. Ensure it is in your antenatal records. Ask your provider about anti-D at twenty-eight weeks and after any sensitising event. If you miscarry, ensure anti-D is given if you are Rh-negative. And if sensitisation has already occurred, ensure you are being cared for by a specialist with experience in managing this in pregnancy.
The intervention is simple. The protection it provides — for this pregnancy and for all future ones — is significant.
This article is for general educational purposes only and does not replace personalised medical advice. Always consult your doctor, midwife, or a qualified healthcare professional about Rh factor management in your specific pregnancy.